| Stage | VRSN | % of rev | RDNW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $443M | 100.00% | $297M | 100.00% | VRSN ×1.49 |
| Gross profit | $393M | 88.76% | $85M | 28.57% | VRSN +60.2pp |
| Operating income | $297M | 66.93% | $18M | 6.03% | VRSN +60.9pp |
| Pre-tax income | $280M | 63.12% | $7M | 2.22% | VRSN +60.9pp |
| Net income | $213M | 47.99% | $7M | 2.19% | VRSN +45.8pp |
| Stage | VRSN | RDNW | Gap · A − B |
|---|---|---|---|
| Revenue | $443M100.00% | $297M100.00% | VRSN ×1.49 |
| Gross profit | 88.76%$393M | 28.57%$85M | VRSN +60.2pp |
| Operating income | 66.93%$297M | 6.03%$18M | VRSN +60.9pp |
| Pre-tax income | 63.12%$280M | 2.22%$7M | VRSN +60.9pp |
None
No disclosed counterparties: VRSN.
| Net income |
| 47.99%$213M |
| 2.19%$7M |
| VRSN +45.8pp |